Osmind Review (2026): Pricing, Strengths, and Who It Fits

Osmind is the psychiatry-specialist EHR, built around measurement-based care and interventional treatment workflows, and it prices like a specialist: $249 per clinician per month for the software plan, before e-prescribing and labs. A solo prescriber writing controlled substances lands around $313 per month plus payment processing. Whether that is money well spent depends almost entirely on your treatment model. If Spravato, ketamine, or TMS is central to your practice, Osmind was built for you. If you run a straightforward cash-pay medication-management practice, you are paying interventional prices for machinery you will not use.

One housekeeping note before the numbers: this is a competitor review. Osmind competes with Eureka, our product. That is exactly why every price below links to Osmind's own published pricing and carries the date we checked it, so you can verify each number yourself.

What does Osmind cost in 2026?

Most review sites still quote Osmind's old Starter plan at $199 and Plus plan at $269. Those plans no longer appear on Osmind's pricing page. As of July 14, 2026, Osmind sells three plans:

The add-ons a prescriber actually configures, same page, same date:

All plans include five admin or staff seats per paid clinician, which is generous; several competitors charge per staff login. Implementation runs one to three weeks on Osmind One. The service tiers quote six to eight weeks after credentialing completes, or four to six months total if you are starting credentialing from scratch, a timeline worth taking seriously if you have a target launch date.

Two of the three plans are priced as a percentage of collections rather than a subscription. We find that structurally interesting, since percentage-of-collections is how Eureka has always priced, and Osmind moving its flagship tiers to the same model suggests the subscription-plus-add-ons era of practice software is ending. The difference is what the percentage buys: Osmind's tiers price insurance revenue cycle work, credentialing, payer contracts, denial management, while Eureka's fee prices the whole cash-pay operation, eRx, notes, superbills, billing, and malpractice coverage included. Which percentage is relevant to you depends on which kind of practice you run.

What does Osmind really cost a solo prescriber?

Take a solo psychiatrist on Osmind One who prescribes controlled substances and orders labs, which describes most cash-pay medication-management practices:

• Base plan: $249
• EPCS: $49
• Lab integration: $15
• Software total: $313 per month, before payment processing at 2.9% + $0.30

On $10,000 of monthly collections, processing adds roughly $300 more, so the platform's real footprint is about $600 a month at that revenue level. For context, that is the most expensive solo configuration in our EHR comparison, roughly double a SimplePractice prescriber build and several times a small Charm practice. Osmind is not trying to win on price, and to its credit it does not pretend to.

What the $313 does not include, as with every EHR in this category, is the rest of the practice: malpractice, billing follow-up, intake chasing, and the 5 to 10 admin hours a week that solo practices report spending on it all. We priced that second column in the full comparison and in the startup budget, so this review stays on the software itself. That second column is also where to compare Osmind against percentage-of-collections platforms, Eureka included: a percentage priced against the whole operation and a subscription priced against software alone are different purchases, and lining their monthly totals up head-to-head misleads in both directions.

What Osmind does well

Measurement-based care is the honest headline. Rating scales are first-class objects in Osmind: scheduled administration, automatic scoring, longitudinal graphs, and a patient app that collects between-visit data. Osmind reports 3.6 million outcomes measured across its network of over 1,000 practices, and whatever you make of vendor network stats, the product's center of gravity is unmistakably outcome tracking. Psychiatrists who want this on a general-purpose platform resort to trending PHQ-9 scores in vitals fields or re-sending forms by hand on a calendar reminder, so a platform where it simply works is a real differentiator. Eureka includes it too, scheduled symptom scales with automatic scoring and visit-to-visit tracking inside the platform fee, so the comparison between the two comes down to depth: Osmind's patient app collects between-visit journal entries and its interventional session flows go further, and a research-minded or Spravato-heavy practice will feel that difference.

Interventional workflows are the other genuine strength. Spravato REMS submissions are automated and cost $4 each, ketamine and TMS treatment flows are native rather than improvised, and the company runs what it calls the largest network of interventional psychiatry practices in the country. A practice doing observed-dosing sessions has compliance work most EHRs have never heard of, and Osmind has clearly sat with those practices and built for them.

The specialty focus shows in smaller ways too. Reviewers on Capterra describe the interface as modern and the note templates as psychiatry-shaped out of the box, in contrast to general medical EHRs where psychiatric documentation gets improvised.

What users report breaking

Public reviews are broadly positive on design and specialty fit, and consistent on a handful of complaints. Across Capterra and Software Advice reviews, the recurring reports as of July 2026:

The most serious one is notes not saving reliably: multiple reviewers describe losing note content to glitches and re-entering their work. For a prescriber, a lost note is a legal-record problem, so make note persistence the first thing you test in a trial.

The rest are ergonomic. The appointment calendar's visual layout draws repeated criticism, and patient self-scheduling has required workarounds. The messaging feature is described as thin, with one oddly persistent complaint being the inability to sort the patient list by last name. Reviewers running startup clinics say the add-on math gets heavy at low patient volume, which matches the $313 floor above. And support reviews split: praise for the team's specialty knowledge sits alongside reports of slow responses and slow-shipping fixes.

None of these are disqualifying on their own, and every EHR's review page has a complaint list. The pattern worth noting is that the complaints cluster in practice-management plumbing, scheduling, messaging, billing ergonomics, while the praise clusters in the clinical layer. That is the profile of a company that built the psychiatry-specific parts first and is backfilling the commodity parts, which is a defensible order of operations but a real day-to-day tradeoff for whoever runs your front desk. In a solo practice, that person is you.

Who Osmind fits, and who it doesn't

Osmind fits you well if: interventional treatment is central to your model. A Spravato or ketamine practice needs REMS automation, observed-session documentation, and outcome graphs a payer or a malpractice carrier will respect, and Osmind is the only platform in our comparison that treats those as core product. The same holds if measurement-based care is your differentiator, or if you are building an insurance practice and want credentialing and revenue cycle management from the same vendor, which is exactly what the percentage-of-collections tiers sell. Note that Osmind's own published implementation timelines put a from-scratch insurance launch at four to six months.

Osmind fits you poorly if: you run, or plan to run, a straightforward cash-pay practice built on intakes, follow-ups, and superbills. You would be paying the specialist premium for REMS automation you never trigger and payer machinery you never touch, while living with the scheduling and messaging rough edges reviewers describe. A cash practice's operational needs are different: card-on-file billing that collects at or near 100%, superbills generated correctly without manual assembly, rating scales that score and track themselves, and EPCS that works from day one. That operational job is the one Eureka prices its own percentage against, and for a cash-pay launch it starts at zero dollars until you collect revenue, which no $313-a-month configuration can match in year one.

"When a psychiatrist tells me they're considering Osmind, my first question is what fraction of their week is interventional," says Juan Rodriguez, MD, the psychiatrist who reviewed this article. "If the answer is a third or more, the specialist tooling pays for itself. If the answer is none, I ask them to name the Osmind feature they'd actually use that a cheaper or more consolidated platform lacks, and the conversation usually ends there."

How to test Osmind before you commit

The same three-transaction trial we recommend for every EHR decision, plus one Osmind-specific check:

1. Write and save a real-length note, then close the tab and reopen it. The most repeated complaint in public reviews is note persistence, so test it deliberately rather than discovering it with a patient chart open.
2. Send a test controlled prescription end to end, including the EPCS identity-proofing setup, and note how long enrollment takes.
3. Complete your own intake as a fake patient, including a scheduled rating scale, and confirm the score lands in the graph without manual entry.
4. Get two things in writing: the current status of the AI scribe on your plan, and your data-export format if you ever leave. The Luminello shutdown taught this specialty that platforms end; export terms are part of the price.

Osmind publishes its pricing, which not every competitor does, and its specialty focus is real. Price the plan against the practice you are actually going to run, not the practice the demo assumes you run.